Supply of Dobutamine Hydrochloride (Pharmaceutical Product)

The contract involves the supply and delivery of two packages of Dobutamine Hydrochloride, a commercial off-the-shelf cardiovascular pharmaceutical used in critical care settings, to a military destination under the jurisdiction of the Defense Logistics Agency within the Department of Defense. The product must adhere to strict regulatory standards for packaging and labeling to ensure safety, efficacy, and compliance with federal pharmaceutical requirements, including full traceability throughout the shipping process from manufacturer to final delivery point. All logistics must support secure, accountable, and timely transport in alignment with military logistics protocols for medical supplies. The procurement is categorized as a subcontract under NAICS code 424210, which pertains to pharmaceutical and biological product merchant wholesalers, indicating the role of a distributor or supplier in the supply chain rather than a direct manufacturer. The solicitation was posted on August 5, 2026, and while specific details such as place of performance, point of contact, or set-aside status are not provided, the contractual obligation centers exclusively on the fulfillment of the two designated packages with full compliance to military and pharmaceutical regulatory frameworks. The contract is referenced through the DIBBS system with specific identifiers for award, delivery, and contract count, ensuring transparency and traceability within the Department of Defense procurement infrastructure.